To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene YWHAZTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
601 supporting clones for gene YWHAZ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA687282 germinal center B cell .a 1 to 455 1 to 456   tiling clone, Submitted on the opposite strand 456/456
(100 %)
12 diff
(97.4 %id)
AA830489 germinal center B cell .a 23 to 435 1 to 412     Submitted on the opposite strand 412/412
(100 %)
6 diff
(98.6 %id)
NM_001135699.1   .a 23 to 3031 1 to 3009   RefSeq, AAA   3009/3009
(100 %)
0 diff
(100 %id)
AA830488 germinal center B cell .a 25 to 435 1 to 410     Submitted on the opposite strand 410/411
(99 %)
9 diff
(97.9 %id)
BI548960 brain, hippocampus .a 27 to 726 1 to 702       702/705
(99 %)
9 diff
(98.8 %id)
BM470707 leiomyosarcoma, uterus .a 31 to 932 31 to 943   tiling clone,   913/1060
(86 %)
28 diff
(97.4 %id)
BQ279163 adenocarcinoma, cell line, breast .a 32 to 829 13 to 815       803/1029
(78 %)
12 diff
(98.9 %id)
TI_44166600   .a 32 to 726 85 to 781       697/784
(88 %)
8 diff
(99.0 %id)
CN276544 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 43 to 791 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
BQ898663 brain, neuroblastoma, cell line .a 44 to 950 1 to 912       912/912
(100 %)
16 diff
(98.3 %id)
BU517040 leiomyosarcoma, uterus .a 49 to 851 1 to 810       810/829
(97 %)
15 diff
(98.2 %id)
BY996029   .a 56 to 761 21 to 726       706/726
(97 %)
5 diff
(99.4 %id)
CN276541 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 68 to 524 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
BI599330 brain, hypothalamus .a 76 to 810 1 to 733       733/733
(100 %)
6 diff
(99.2 %id)
BI668061 brain, hypothalamus .a 79 to 828 1 to 750       750/751
(99 %)
7 diff
(99.1 %id)
TI_45212180   .a 81 to 810 93 to 820       728/820
(88 %)
7 diff
(99.2 %id)
CB045508 colon, juvenile granulosa tumor .a 82 to 554 1 to 474       474/474
(100 %)
6 diff
(98.8 %id)
BQ441212 leiomyosarcoma, uterus .a 84 to 998 1 to 917       917/917
(100 %)
6 diff
(99.4 %id)
TI_44346470   .a 84 to 828 95 to 839       745/840
(88 %)
8 diff
(99.1 %id)
DB487253 hypothalamus .a 88 to 526 1 to 438       438/438
(100 %)
3 diff
(99.4 %id)
DB490332 hypothalamus .a 88 to 290 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
BG168428 hypernephroma, cell line, Kidney .a 94 to 758 1 to 675       675/1004
(67 %)
40 diff
(96.1 %id)
BX409711 brain, fetal brain .a 95 to 608 1 to 513       513/513
(100 %)
21 diff
(96.0 %id)
BU160871 melanotic melanoma, skin .a 96 to 951 1 to 859       859/859
(100 %)
6 diff
(99.4 %id)
BI553394 brain, hippocampus .a 104 to 848 1 to 743       743/744
(99 %)
11 diff
(98.6 %id)
CD653020 Embryonic Stem cells .a 105 to 869 12 to 775       764/775
(98 %)
10 diff
(98.8 %id)
AA331246 Embryo, 8 weeks .a 108 to 374 1 to 267       267/267
(100 %)
0 diff
(100 %id)
TI_44170231   .a 111 to 848 91 to 826       736/827
(88 %)
12 diff
(98.6 %id)
BM550052 astrocytoma grade IV, cell line, brain .a 125 to 1088 24 to 989       966/1032
(93 %)
20 diff
(98.1 %id)
BX283624 astrocytoma grade IV, cell line, brain .a 129 to 636 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
BE783803 eye, retinoblastoma .a 129 to 855 1 to 719       719/923
(77 %)
18 diff
(98.1 %id)
BE896855 melanotic melanoma, skin .a 130 to 593 1 to 474       472/543
(86 %)
19 diff
(96.6 %id)
BU175292 embryonal carcinoma, cell line, testis .a 131 to 932 1 to 813       813/851
(95 %)
14 diff
(98.4 %id)
BU182192 eye, retinoblastoma .a 131 to 1013 1 to 885       885/885
(100 %)
5 diff
(99.5 %id)
BU170982 eye, retinoblastoma .a 131 to 1014 1 to 884       884/885
(99 %)
7 diff
(99.3 %id)
DB506109 hypothalamus .a 133 to 637 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
AK289945 hippocampus .a 137 to 1351 8 to 1222   tiling clone,   1215/1215
(100 %)
0 diff
(100 %id)
DC331549 hippocampus .a 137 to 695 8 to 566       559/559
(100 %)
0 diff
(100 %id)
CN276528 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 139 to 865 1 to 727       727/727
(100 %)
4 diff
(99.5 %id)
CN276569 embryonic stem cells, DMSO-treated H9 cellline .a 140 to 798 1 to 659       659/659
(100 %)
2 diff
(99.7 %id)
BQ425092 melanotic melanoma, skin .a 142 to 937 24 to 827       804/906
(88 %)
24 diff
(97.4 %id)
CN276551 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 143 to 876 1 to 734       734/734
(100 %)
0 diff
(100 %id)
CN276613 embryonic stem cells, cell lines H1, H7, andH9 .a 143 to 797 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
CN276617 embryonic stem cells, DMSO-treated H9 cellline .a 143 to 458 1 to 316       316/316
(100 %)
0 diff
(100 %id)
BG679358 skin, squamous cell carcinoma .a 143 to 865 59 to 780       722/809
(89 %)
35 diff
(95.7 %id)
BG391244 embryonal carcinoma, cell line, testis .a 144 to 953 1 to 807       807/875
(92 %)
20 diff
(97.8 %id)
CR993518 T-Lymphocytes .a 145 to 724 1 to 578       578/581
(99 %)
4 diff
(99.4 %id)
CN276632 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 146 to 840 1 to 696       696/699
(99 %)
3 diff
(99.6 %id)
BE885292 leiomyosarcoma, uterus .a 147 to 854 1 to 703       705/770
(91 %)
15 diff
(98.1 %id)
BY995774   .a 148 to 832 9 to 693       685/693
(98 %)
6 diff
(99.2 %id)
CN276561 embryonic stem cells, DMSO-treated H9 cellline .a 149 to 479 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
AW630116 2 pooled high-grade transitional celltumors, genitourinary tract .a 157 to 687 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
CB045507 colon, juvenile granulosa tumor .a 2696 to 3029 370 to 37   tiling clone, AAA   334/341
(97 %)
10 diff
(97.1 %id)
NM_001135701.1   .b 1 to 3012 1 to 3012 exact RefSeq, AAA   3012/3012
(100 %)
0 diff
(100 %id)
CN276627 embryonic stem cells, DMSO-treated H9 cellline .b 56 to 787 1 to 732   tiling clone,   732/732
(100 %)
4 diff
(99.5 %id)
BU153643 eye, retinoblastoma .b 77 to 944 1 to 876   tiling clone,   876/877
(99 %)
10 diff
(98.9 %id)
BI906804 leukocyte .c 1 to 814 1 to 814 R95M K193Q E194G M195N Q196A ... tiling clone,   814/817
(99 %)
12 diff
(98.6 %id)
TI_57233259   .c 3 to 814 32 to 843       812/846
(95 %)
16 diff
(98.2 %id)
CR606956 fetal liver .c 55 to 2301 1 to 2247   tiling clone,   2247/2247
(100 %)
0 diff
(100 %id)
AL531286 brain, fetal liver, Liver, neuroblastoma cells .c 55 to 1081 1 to 1019       1019/1019
(100 %)
14 diff
(98.7 %id)
BF833046 head_neck .c 644 to 1044 406 to 1     Submitted on the opposite strand 406/406
(100 %)
14 diff
(96.6 %id)
BX411390 fetal liver, Liver .c 666 to 1566 899 to 1       899/910
(98 %)
6 diff
(99.4 %id)
AI904564 breast .c 699 to 1299 615 to 17       599/617
(97 %)
0 diff
(100 %id)
AL564011 brain, fetal liver, Liver, neuroblastoma cells .c 1227 to 2269 1065 to 35       1031/1080
(95 %)
0 diff
(100 %id)
DB290184 uterus .c 1476 to 2042 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AW275602 normal squamous epithelium, tongue .c 1797 to 1975 9 to 187     Submitted on the opposite strand 179/187
(95 %)
6 diff
(96.8 %id)
CX781817 human embryonic stem cells .d 1 to 876 1 to 876 exact tiling clone,   876/876
(100 %)
0 diff
(100 %id)
AI373162 B-cell, chronic lymphotic leukemia .e 1 to 840 1 to 837   tiling clone, Submitted on the opposite strand 837/879
(95 %)
27 diff
(97.0 %id)
CX873753 embryonic stem .e 409 to 1160 1 to 752 exact tiling clone,   752/752
(100 %)
2 diff
(99.8 %id)
AA113845 Pancreas .f 1 to 324 1 to 325   tiling clone,   325/325
(100 %)
18 diff
(94.5 %id)
AA113132 Pancreas .f 2717 to 3140 427 to 1   tiling clone,   427/432
(98 %)
3 diff
(99.4 %id)
CR982709 T-Lymphocytes .g 1 to 848 1 to 854   tiling clone,   854/857
(99 %)
7 diff
(99.2 %id)
AL516034 brain, neuroblastoma, neuroblastoma cells .g 115 to 994 1 to 880 K120X E154X T215X E241X tiling clone,   880/880
(100 %)
0 diff
(100 %id)
CR983119 T-Lymphocytes .g 123 to 686 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
AL516033 brain, neuroblastoma, neuroblastoma cells .g 2875 to 2988 114 to 1   tiling clone,   900/967
(93 %)
52 diff
(94.7 %id)
BE676649 B-cell, chronic lymphotic leukemia .h 1 to 407 1 to 407   tiling clone, Submitted on the opposite strand 407/407
(100 %)
1 diff
(99.8 %id)
BC051814 Skin, melanotic melanoma. .h 268 to 3238 1 to 2974 exact tiling clone, available from MGC, AAA   2974/2974
(100 %)
3 diff
(99.9 %id)
BM453233 melanotic melanoma, skin .h 268 to 1017 1 to 756   available from MGC,   756/952
(79 %)
19 diff
(98.1 %id)
AL546801.
matches multiple genes
placenta, Placenta Cot 25-normalized .h 344 to 1403 1 to 1041 N4X N50X N95X K120X A134R ...   also hits gene flarslaw 1041/1060
(98 %)
27 diff
(97.5 %id)
BI461608 testis .h 372 to 1071 1 to 710       710/832
(85 %)
27 diff
(96.8 %id)
NM_001135700.1   .h 385 to 3347 1 to 2963 exact RefSeq, AAA   2963/2963
(100 %)
0 diff
(100 %id)
CR996247 T-Lymphocytes .h 385 to 1271 1 to 888 L170S A171G L172P N173* tiling clone,   888/895
(99 %)
3 diff
(99.7 %id)
CN276590 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 414 to 1155 8 to 749       742/749
(99 %)
6 diff
(99.2 %id)
DB446582 testis .h 422 to 851 1 to 431       431/431
(100 %)
11 diff
(97.5 %id)
CX762227 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 434 to 1141 1 to 702     Submitted on the opposite strand 702/843
(83 %)
14 diff
(98.4 %id)
DB442347 testis .h 439 to 884 1 to 447       443/447
(99 %)
15 diff
(96.7 %id)
CN276531 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 442 to 1194 1 to 754       754/754
(100 %)
2 diff
(99.8 %id)
CN276606 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 458 to 1131 1 to 674       674/674
(100 %)
0 diff
(100 %id)
DB472116 hippocampus .i 1 to 499 1 to 499   tiling clone,   499/499
(100 %)
1 diff
(99.8 %id)
BQ605329 breast .i 18 to 486 469 to 1     Submitted on the opposite strand 469/479
(97 %)
3 diff
(99.4 %id)
NM_001135702.1   .i 18 to 3048 1 to 3031 exact RefSeq, AAA   3031/3031
(100 %)
0 diff
(100 %id)
BG394367 eye, retinoblastoma .i 31 to 777 1 to 747       747/975
(76 %)
30 diff
(97.0 %id)
BU184290 eye, retinoblastoma .i 37 to 776 1 to 751   tiling clone,   751/923
(81 %)
14 diff
(98.5 %id)
AL553839 placenta, Placenta Cot 25-normalized .i 100 to 1091 1 to 980 E84V K85E I86N E87* tiling clone,   980/980
(100 %)
30 diff
(97.0 %id)
BQ427454 melanotic melanoma, skin .i 116 to 993 1 to 889 N50H R222E D223R N224Q T226D ...     889/892
(99 %)
25 diff
(97.2 %id)
DR762546 embryonic stem .i 146 to 1024 1 to 879 exact tiling clone,   879/879
(100 %)
0 diff
(100 %id)
AL576727 placenta, Placenta Cot 25-normalized .i 1918 to 2866 936 to 1   tiling clone,   936/997
(93 %)
29 diff
(97.1 %id)
BI769698 pooled lung and spleen .j 1 to 912 1 to 941   tiling clone,   852/1038
(82 %)
34 diff
(96.8 %id)
TI_57179862   .j 1 to 912 30 to 970       913/1067
(85 %)
47 diff
(95.6 %id)
BX441333.
matches multiple genes
brain, fetal brain .j 2 to 951 1 to 950     also hits gene VPS45 950/950
(100 %)
1 diff
(99.9 %id)
CN276576 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 5 to 628 13 to 636   tiling clone,   624/637
(97 %)
6 diff
(99.1 %id)
CN276547 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 11 to 521 1 to 512       512/512
(100 %)
5 diff
(99.1 %id)
BE869356 adenocarcinoma, colon .j 92 to 693 1 to 602       602/746
(80 %)
11 diff
(98.6 %id)
BG704934 brain, hippocampus .j 100 to 806 1 to 700       700/704
(99 %)
15 diff
(97.9 %id)
BE895302 melanotic melanoma, skin .j 107 to 756 1 to 658       658/871
(75 %)
19 diff
(97.9 %id)
CN276619 embryonic stem cells, cell lines H1, H7, andH9 .j 123 to 397 1 to 275       275/275
(100 %)
1 diff
(99.7 %id)
NM_145690.2   .j 123 to 3188 1 to 3066 exact RefSeq, AAA   3066/3066
(100 %)
0 diff
(100 %id)
DB461758 testis .j 150 to 625 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
TI_44000619   .j 180 to 893 93 to 813       721/813
(88 %)
21 diff
(97.5 %id)
TI_44166535   .j 181 to 1011 83 to 910       826/1000
(82 %)
23 diff
(97.7 %id)
TI_44345644   .j 195 to 912 80 to 803       724/928
(78 %)
14 diff
(98.5 %id)
BQ229366 embryonal carcinoma, cell line, testis .j 197 to 1076 1 to 893 L216P I217N M218N Q219A L220I ...     893/902
(99 %)
17 diff
(98.2 %id)
CV569488 cornea, eye .j 203 to 822 1 to 620       620/620
(100 %)
0 diff
(100 %id)
CR988376 T-Lymphocytes .j 203 to 1115 1 to 915 A192C T194D A195S D197*     915/922
(99 %)
6 diff
(99.4 %id)
BQ669413 epidermoid carcinoma, cell line, salivary gland .j 207 to 1022 1 to 822       820/947
(86 %)
14 diff
(98.6 %id)
BQ675131 epidermoid carcinoma, cell line, salivary gland .j 207 to 1145 1 to 941 Q233P G242R G243R E244G N245K     941/941
(100 %)
6 diff
(99.4 %id)
BQ673299 epidermoid carcinoma, cell line, salivary gland .j 207 to 1007 1 to 800       800/937
(85 %)
12 diff
(98.8 %id)
BC099904 testis .j 208 to 2064 1 to 1862 exact AAA   1862/1862
(100 %)
2 diff
(99.9 %id)
TI_44169765   .j 208 to 1010 87 to 897       811/918
(88 %)
25 diff
(97.3 %id)
TI_44350685   .j 208 to 934 129 to 855       727/857
(84 %)
8 diff
(99.1 %id)
BC068456 Brain, hypothalamus .j 209 to 3035 1 to 2832 M22V available from MGC, AAA   2832/2832
(100 %)
7 diff
(99.8 %id)
TI_45212247   .j 209 to 1031 89 to 916       828/916
(90 %)
17 diff
(98.2 %id)
TI_45213258   .j 209 to 917 124 to 835       712/923
(77 %)
16 diff
(98.3 %id)
TI_45213913   .j 209 to 828 89 to 710       622/710
(87 %)
11 diff
(98.5 %id)
U28964 bone marrow .j 209 to 1238 1 to 1030 exact     1030/1030
(100 %)
0 diff
(100 %id)
CR623456 fetal brain .j 210 to 1771 1 to 1562 exact     1562/1562
(100 %)
0 diff
(100 %id)
BX440479 brain, fetal brain .j 210 to 947 1 to 738   fully sequenced,   738/738
(100 %)
1 diff
(99.9 %id)
TI_45216267   .j 211 to 1022 124 to 947       824/955
(86 %)
31 diff
(96.8 %id)
DB474734 hippocampus .j 212 to 717 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DB474780 hippocampus .j 212 to 722 1 to 511       511/514
(99 %)
1 diff
(99.9 %id)
DB489777 hypothalamus .j 212 to 680 1 to 470       470/470
(100 %)
4 diff
(99.2 %id)
TI_57217797   .j 212 to 924 28 to 737       710/744
(95 %)
15 diff
(98.0 %id)
BQ882702 eye, normal pigmented retinal epithelium .j 218 to 1011 1 to 797       797/957
(83 %)
13 diff
(98.7 %id)
BC108281 Eye, retinoblastoma .j 220 to 3037 1 to 2818 exact AAA   2818/2818
(100 %)
0 diff
(100 %id)
TI_154153662   .j 220 to 834 80 to 694       615/615
(100 %)
1 diff
(99.9 %id)
BM153604 leukopheresis .j 221 to 692 1 to 469       469/469
(100 %)
7 diff
(98.6 %id)
TI_154137863   .j 222 to 766 80 to 623       544/577
(94 %)
7 diff
(98.8 %id)
BU845943 ovary, teratocarcinoma, cell line .j 223 to 1127 1 to 908 G242R G243R E244G N245K     908/913
(99 %)
6 diff
(99.4 %id)
CN276540 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 224 to 964 1 to 741       741/741
(100 %)
1 diff
(99.9 %id)
TI_44169345   .j 224 to 915 124 to 826       703/953
(73 %)
23 diff
(97.6 %id)
TI_45214736   .j 224 to 1008 118 to 908       791/1033
(76 %)
23 diff
(97.8 %id)
TI_44344872   .j 226 to 1009 80 to 870       791/903
(87 %)
27 diff
(97.1 %id)
BC072426 Eye, retinoblastoma .j 228 to 3079 1 to 2852 exact tiling clone, available from MGC, AAA   2852/2852
(100 %)
0 diff
(100 %id)
BQ430680 embryonal carcinoma, cell line, testis .j 229 to 1197 1 to 965 G240R G242R G243R     965/1079
(89 %)
16 diff
(98.6 %id)
BQ420811 embryonal carcinoma, cell line, testis .j 229 to 1090 1 to 869 E202D W228V T229D S230I D231G ...     869/870
(99 %)
11 diff
(98.8 %id)
BU181785 eye, retinoblastoma .j 229 to 1096 1 to 873 D235R E236R A237S E238*     873/877
(99 %)
6 diff
(99.4 %id)
BU507023 leiomyosarcoma, uterus .j 229 to 1110 1 to 886 K139X R222E D223R N224H W228G ...     886/888
(99 %)
15 diff
(98.4 %id)
BC083508 Skin, melanotic melanoma. .j 230 to 3037 1 to 2812 exact AAA   2812/2812
(100 %)
2 diff
(100.0 %id)
CR982613 T-Lymphocytes .j 230 to 909 1 to 679       679/709
(95 %)
1 diff
(99.9 %id)
BM471122 melanotic melanoma, skin .j 231 to 1212 1 to 986 G242R G243R E244G N245K     986/997
(98 %)
9 diff
(99.1 %id)
BC013265 Eye, retinoblastoma .j 232 to 3037 1 to 2806 exact available from MGC, AAA   2806/2806
(100 %)
0 diff
(100 %id)
CX759668 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 232 to 916 1 to 684     Submitted on the opposite strand 684/684
(100 %)
0 diff
(100 %id)
BM147478 leukopheresis .j 234 to 600 1 to 368       368/368
(100 %)
7 diff
(98.1 %id)
BM149323 leukopheresis .j 234 to 743 1 to 510       510/511
(99 %)
3 diff
(99.5 %id)
BM153651 leukopheresis .j 234 to 662 1 to 429       429/429
(100 %)
7 diff
(98.4 %id)
DB473403 hippocampus .j 235 to 722 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DB481465 hippocampus .j 235 to 712 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
BU182653 leiomyosarcoma, uterus .j 235 to 1080 1 to 854 F177V E180G I181D L182S N183E ...     854/866
(98 %)
15 diff
(98.3 %id)
TI_44165313   .j 235 to 1011 127 to 913       787/937
(83 %)
28 diff
(97.1 %id)
TI_44166006   .j 235 to 1030 128 to 929       802/929
(86 %)
21 diff
(97.8 %id)
TI_45211409   .j 235 to 1020 128 to 920       793/941
(84 %)
32 diff
(96.6 %id)
BM763084 myeloma .j 235 to 946 1 to 711       711/711
(100 %)
4 diff
(99.5 %id)
TI_44168759   .j 236 to 1001 88 to 860       773/860
(89 %)
17 diff
(98.1 %id)
TI_44165947   .j 238 to 958 151 to 870       720/870
(82 %)
6 diff
(99.4 %id)
DB455687 testis .j 243 to 725 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
CN276520 embryonic stem cells, cell lines H1, H7, andH9 .j 244 to 997 1 to 754       754/754
(100 %)
0 diff
(100 %id)
CN276573 embryonic stem cells, cell lines H1, H7, andH9 .j 244 to 970 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
CN276609 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 246 to 834 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CN276616 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 246 to 917 1 to 672       672/679
(98 %)
2 diff
(99.8 %id)
CR624253 B cells (Ramos cell line) .j 246 to 2066 1 to 1821 exact     1821/1821
(100 %)
0 diff
(100 %id)
BX421368 B cells (Ramos cell line) .j 246 to 1262 1 to 1010 exact fully sequenced,   1010/1010
(100 %)
3 diff
(99.8 %id)
BU507141 leiomyosarcoma, uterus .j 246 to 1140 1 to 896 Q233P G234R A239S G240R G243R     896/896
(100 %)
8 diff
(99.2 %id)
DR158504 human embryonic stem cells differentiated toan early endodermal cell type .j 246 to 1028 1 to 783       783/783
(100 %)
0 diff
(100 %id)
TI_59382147   .j 246 to 1010 121 to 897       775/800
(96 %)
37 diff
(95.4 %id)
BU167004 melanotic melanoma, skin .j 247 to 1068 1 to 830       828/845
(97 %)
13 diff
(98.5 %id)
BY996807   .j 248 to 921 17 to 690       674/690
(97 %)
6 diff
(99.2 %id)
TI_44166228   .j 249 to 938 84 to 775       690/775
(89 %)
11 diff
(98.6 %id)
BX442589 brain, fetal brain .j 252 to 1314 1 to 1051 M218X Q219X L220X R222X E241X ...     1051/1091
(96 %)
20 diff
(98.2 %id)
BQ962851 leiomyosarcoma, uterus .j 252 to 1145 1 to 908 K212X L225F T226D L227I W228C ...     908/909
(99 %)
20 diff
(97.8 %id)
CV801663 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 252 to 917 1 to 665       665/856
(77 %)
4 diff
(99.6 %id)
BX421326 B cells (Ramos cell line) .j 253 to 1336 1 to 1075 exact AAA   1075/1122
(95 %)
10 diff
(99.2 %id)
BE888207 leiomyosarcoma, uterus .j 253 to 865 1 to 613       613/614
(99 %)
1 diff
(99.9 %id)
BM470388 eye, retinoblastoma .j 253 to 1174 1 to 933 A199S M218N Q219A G234X E236X ...     933/1011
(92 %)
21 diff
(98.0 %id)
CR612878 fetal brain .j 254 to 1630 1 to 1377 exact     1377/1377
(100 %)
0 diff
(100 %id)
CN276562 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 255 to 997 1 to 743       743/743
(100 %)
0 diff
(100 %id)
TI_57230158   .j 258 to 1018 85 to 846       762/789
(96 %)
8 diff
(99.0 %id)
BU150837 dorsal root ganglia .j 259 to 1089 1 to 837 D235R E236R A237S E238*     837/873
(95 %)
7 diff
(99.2 %id)
BQ478539 insulinoma, Pancreas .j 260 to 865 8 to 613       606/613
(98 %)
8 diff
(98.7 %id)
TI_927046145   .j 263 to 1095 118 to 956 L172P N173*   Submitted on the opposite strand 839/1091
(76 %)
17 diff
(98.5 %id)
TI_927047474   .j 263 to 1095 875 to 41 exact   Submitted on the opposite strand 835/1258
(66 %)
6 diff
(99.6 %id)
TI_1242416208   .j 263 to 1095 868 to 35 exact   Submitted on the opposite strand 834/1286
(64 %)
6 diff
(99.6 %id)
TI_1242419130   .j 263 to 915 670 to 17       654/1221
(53 %)
6 diff
(99.6 %id)
CR623658 neuroblastoma .j 267 to 2025 1 to 1759 exact     1759/1759
(100 %)
0 diff
(100 %id)
TI_927045711   .j 269 to 1095 60 to 883 Q233H G234E D235T E236K A237L ...   Submitted on the opposite strand 824/1079
(76 %)
16 diff
(98.6 %id)
CR988590 T-Lymphocytes .j 269 to 947 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
TI_44172220   .j 270 to 1042 119 to 891       773/891
(86 %)
12 diff
(98.7 %id)
BC073141 Uterus, leiomyosarcoma .j 274 to 3037 1 to 2764 exact available from MGC, AAA   2764/2764
(100 %)
3 diff
(99.9 %id)
BC101483 Brain, cerebral cortex, PCR rescued clones .j 275 to 1093 1 to 819 exact     819/819
(100 %)
0 diff
(100 %id)
BC111951 Brain, cerebral cortex, PCR rescued clones .j 275 to 1088 1 to 814 exact     814/814
(100 %)
0 diff
(100 %id)
CR996810 T-Lymphocytes .j 275 to 1157 1 to 883 exact     883/883
(100 %)
2 diff
(99.8 %id)
ES307816 beard hair, skin .j 277 to 515 1 to 238       238/238
(100 %)
1 diff
(99.6 %id)
BM903995 eye, retinoblastoma .j 277 to 1255 1 to 985 D223X N224H Q233X     985/986
(99 %)
19 diff
(98.1 %id)
BQ438223 leiomyosarcoma, uterus .j 277 to 1145 1 to 871 A188P C189A S190L A192Q K193R ...     871/873
(99 %)
10 diff
(98.9 %id)
BQ049153 lymph, lymphoma, cell line .j 279 to 1222 1 to 965 N224X D235R E236R A237S E238*     965/1024
(94 %)
34 diff
(96.7 %id)
BU159413 eye, retinoblastoma .j 279 to 1134 1 to 855 exact     855/855
(100 %)
4 diff
(99.6 %id)
BU169987 embryonal carcinoma, cell line, testis .j 280 to 1120 1 to 846 D223X N224H E241R E244G N245K     846/898
(94 %)
13 diff
(98.6 %id)
BQ233071 epithelioid carcinoma, Pancreas .j 280 to 1089 1 to 814 G240R E241R G242R G243R E244G ...     814/848
(95 %)
6 diff
(99.3 %id)
BQ437985 melanotic melanoma, skin .j 284 to 1112 1 to 835 Q233P G234R D235R E236R A237S ...     835/890
(93 %)
8 diff
(99.2 %id)
BQ057440 lymph, lymphoma, cell line .j 291 to 1218 1 to 934 Q233P G234R D235R E236R A237S ...     934/1027
(90 %)
18 diff
(98.3 %id)
BU944666 adenocarcinoma, cell line, breast .j 295 to 1230 1 to 938 G240X     938/941
(99 %)
16 diff
(98.3 %id)
AL542785 placenta .j 297 to 1184 1 to 888 exact     888/888
(100 %)
0 diff
(100 %id)
AL517674 brain, neuroblastoma, neuroblastoma cells .j 298 to 1368 1 to 1062 R18A Y19I D20*     1062/1088
(97 %)
15 diff
(98.7 %id)
CX870884 embryonic stem .j 302 to 1162 1 to 861 exact     861/861
(100 %)
0 diff
(100 %id)
BG394035 embryonal carcinoma, cell line, testis .j 314 to 1093 57 to 838 T226H L227I W228V T229E S230H ...     782/1092
(71 %)
12 diff
(99.0 %id)
BI259634 cervical carcinoma cell line, cervix .j 316 to 1030 1 to 714       714/714
(100 %)
2 diff
(99.8 %id)
BX440478 brain, fetal brain .j 886 to 1771 885 to 1   fully sequenced,   885/885
(100 %)
0 diff
(100 %id)
BX435875 B cells (Ramos cell line) .j 1232 to 2066 841 to 1   fully sequenced,   841/841
(100 %)
8 diff
(99.1 %id)
BQ478291 insulinoma, Pancreas .j 1437 to 2075 653 to 15   AAA   639/639
(100 %)
0 diff
(100 %id)
AL542784 placenta .j 2063 to 3010 948 to 1       948/948
(100 %)
2 diff
(99.8 %id)
AL517673 brain, neuroblastoma, neuroblastoma cells .j 2108 to 3143 1027 to 2   tiling clone,   1026/1084
(94 %)
0 diff
(100 %id)
CU448323 epidermis .k 1 to 353 21 to 373   tiling clone,   353/375
(94 %)
8 diff
(97.9 %id)
DC298291 adrenal gland .k 343 to 925 1 to 583   tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
NM_003406.3   .k 343 to 3334 1 to 2992 exact RefSeq, AAA   2992/2992
(100 %)
0 diff
(100 %id)
AL546430 placenta, Placenta Cot 25-normalized .k 361 to 1390 1 to 1021 K120E     1021/1035
(98 %)
27 diff
(97.4 %id)
AL514198 neuroblastoma, placenta .k 362 to 1460 1 to 1092 exact     1092/1149
(95 %)
12 diff
(99.0 %id)
DB448661 testis .k 364 to 602 1 to 239       239/243
(98 %)
6 diff
(97.6 %id)
CB961486 placenta, pre-eclamptic placenta .k 364 to 1040 28 to 707       680/713
(95 %)
15 diff
(97.9 %id)
AA081673   .k 368 to 693 1 to 330       330/330
(100 %)
10 diff
(97.0 %id)
CD652775 Embryonic Stem cells .k 373 to 1131 9 to 758       750/822
(91 %)
16 diff
(98.1 %id)
BG754890 B-cells, primary B-cells from tonsils (cell line) .k 374 to 1132 1 to 759       759/759
(100 %)
7 diff
(99.1 %id)
CD652605 Embryonic Stem cells .k 374 to 1158 11 to 794       784/848
(92 %)
19 diff
(97.8 %id)
BU170501 eye, retinoblastoma .k 375 to 1262 1 to 890 D235R E236R A237N E238*     890/890
(100 %)
6 diff
(99.4 %id)
BQ889291 dorsal root ganglia .k 379 to 1303 1 to 934 L170P A171G L172P N173L F174T ...     934/938
(99 %)
33 diff
(96.5 %id)
BQ430685 large cell carcinoma, lung .k 382 to 1249 1 to 868 N245X     868/868
(100 %)
0 diff
(100 %id)
BM556134 duodenal adenocarcinoma, cell line, small intestine .k 384 to 1314 1 to 939 T163A Y211X K212Q L220I Q233P ...     939/975
(96 %)
20 diff
(98.0 %id)
BG392263 embryonal carcinoma, cell line, testis .k 385 to 1227 1 to 844 D204G T205Y L206I S207Q E208V ...     844/876
(96 %)
19 diff
(97.9 %id)
BQ232739 large cell carcinoma, lung .k 385 to 1262 1 to 887 S230X D231G T232Y Q233P G234X ...     887/892
(99 %)
10 diff
(98.9 %id)
AW407681 lymph .k 387 to 782 8 to 403       396/403
(98 %)
6 diff
(98.6 %id)
TI_154146263   .k 387 to 1062 82 to 759       678/678
(100 %)
22 diff
(96.8 %id)
BG390833 embryonal carcinoma, cell line, testis .k 397 to 1166 1 to 768       768/1052
(73 %)
19 diff
(98.2 %id)
M86400 placenta .k 397 to 3225 1 to 2834 exact     2834/2834
(100 %)
3 diff
(99.9 %id)
AV653142 corresponding non cancerous liver tissue .k 399 to 784 1 to 386     Submitted on the opposite strand 386/386
(100 %)
0 diff
(100 %id)
CR614741 B cells (Ramos cell line) .k 408 to 2196 1 to 1789 exact tiling clone,   1789/1789
(100 %)
0 diff
(100 %id)
AL560027 B cells (Ramos cell line), B cells from Burkitt lymphoma .k 408 to 1367 1 to 955 G71X fully sequenced,   955/955
(100 %)
3 diff
(99.7 %id)
AA361249   .k 433 to 704 1 to 272       272/272
(100 %)
0 diff
(100 %id)
CV573833 cornea, eye .k 460 to 1076 1 to 617       617/617
(100 %)
6 diff
(99.1 %id)
DB470112 hippocampus .k 464 to 895 14 to 459       452/459
(98 %)
31 diff
(93.3 %id)
CR625952 fetal brain .k 470 to 2195 3 to 1728 exact     1728/1728
(100 %)
0 diff
(100 %id)
BX461328 brain, fetal brain .k 470 to 1559 4 to 1079 exact     1079/1099
(98 %)
20 diff
(98.2 %id)
BM451803 eye, retinoblastoma .k 474 to 1279 1 to 816 G240R G243R E244G N245K     816/899
(90 %)
11 diff
(98.8 %id)
TI_45214945   .k 477 to 1178 129 to 832       704/832
(84 %)
7 diff
(99.2 %id)
BE244031 leukopheresis .k 494 to 854 1 to 360       360/360
(100 %)
6 diff
(98.4 %id)
CN276595 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 507 to 1148 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CN276519 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 513 to 1142 1 to 630       630/630
(100 %)
0 diff
(100 %id)
CN276580 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 513 to 1142 1 to 630       630/630
(100 %)
0 diff
(100 %id)
CN276630 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 514 to 1164 1 to 651       651/651
(100 %)
0 diff
(100 %id)
CN276530 embryonic stem cells, DMSO-treated H9 cellline .k 522 to 1199 1 to 679       679/679
(100 %)
1 diff
(99.9 %id)
S79449   .k 528 to 737 1 to 210       210/210
(100 %)
0 diff
(100 %id)
BX336301 Placenta Cot 25-normalized .k 536 to 1362 1 to 827       827/827
(100 %)
0 diff
(100 %id)
BM458119 leiomyosarcoma, uterus .k 544 to 1492 1 to 963       963/1044
(92 %)
22 diff
(97.9 %id)
AU128858   .k 562 to 1197 2 to 640   capped   639/639
(100 %)
6 diff
(99.1 %id)
BQ921139 leiomyosarcoma, uterus .k 575 to 1480 1 to 909       909/912
(99 %)
14 diff
(98.5 %id)
TI_57192788   .k 577 to 1214 54 to 690       637/637
(100 %)
1 diff
(99.9 %id)
CR989146 T-Lymphocytes .k 580 to 1438 1 to 860       860/870
(98 %)
2 diff
(99.8 %id)
R51717 whole brain .k 589 to 682 1 to 94       94/94
(100 %)
0 diff
(100 %id)
CN276554 embryonic stem cells, cell lines H1, H7, andH9 .k 597 to 1261 1 to 665       665/665
(100 %)
2 diff
(99.7 %id)
BG503315 embryonal carcinoma, testis .k 603 to 1356 1 to 752       752/755
(99 %)
9 diff
(98.9 %id)
BU176764 eye, retinoblastoma .k 604 to 1494 1 to 897       897/914
(98 %)
23 diff
(97.5 %id)
BU181192 embryonal carcinoma, cell line, testis .k 608 to 1405 1 to 808       808/866
(93 %)
30 diff
(96.6 %id)
AU143723   .k 619 to 1458 2 to 840   capped   839/847
(99 %)
11 diff
(98.8 %id)
BE787270 large cell carcinoma, lung .k 634 to 1324 1 to 688       688/692
(99 %)
7 diff
(99.0 %id)
CR611466 fetal brain .k 643 to 2196 1 to 1554       1554/1554
(100 %)
0 diff
(100 %id)
TI_154138629   .k 655 to 1163 81 to 589       509/509
(100 %)
0 diff
(100 %id)
BQ962895 leiomyosarcoma, uterus .k 663 to 1515 1 to 863       863/864
(99 %)
10 diff
(98.9 %id)
BU160240 leiomyosarcoma, uterus .k 667 to 1504 1 to 845       845/914
(92 %)
11 diff
(98.8 %id)
BM479674 embryonal carcinoma, cell line, testis .k 668 to 1700 1 to 1040       1040/1040
(100 %)
21 diff
(98.0 %id)
BM768117 Ascites, stomach .k 679 to 1359 1 to 681       681/681
(100 %)
0 diff
(100 %id)
BM770225 Ascites, stomach .k 679 to 1284 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM770613 Ascites, stomach .k 679 to 1372 1 to 694       694/694
(100 %)
0 diff
(100 %id)
DA794050 brain .k 683 to 1327 2 to 646   capped   645/645
(100 %)
0 diff
(100 %id)
TI_57229459   .k 694 to 1440 54 to 798       745/746
(99 %)
7 diff
(99.1 %id)
BI870540 adenocarcinoma, cell line, Liver .k 695 to 1440 1 to 744       744/745
(99 %)
7 diff
(99.1 %id)
CB054640 brain, glioblastoma (pooled) .k 697 to 1356 9 to 668       660/668
(98 %)
0 diff
(100 %id)
TI_45209675   .k 712 to 1436 83 to 804       722/805
(89 %)
11 diff
(98.7 %id)
CN276610 embryonic stem cells, cell lines H1, H7, andH9 .k 719 to 1358 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
BM475849 eye, retinoblastoma .k 722 to 1701 1 to 988       988/1041
(94 %)
36 diff
(96.6 %id)
DT217487 brain .k 729 to 1380 1 to 652       652/652
(100 %)
0 diff
(100 %id)
N84196   .k 731 to 902 1 to 164       164/183
(89 %)
12 diff
(93.5 %id)
BM802034 duodenal adenocarcinoma, cell line, small intestine .k 735 to 1816 1 to 1085       1085/1091
(99 %)
58 diff
(94.7 %id)
CN276600 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 737 to 1471 1 to 735       735/735
(100 %)
0 diff
(100 %id)
BG743685 skin .k 762 to 1470 1 to 708       708/708
(100 %)
1 diff
(99.9 %id)
BJ992011 hepatoblastoma .k 801 to 1327 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BM455983 lymph, lymphoma, cell line .k 816 to 1835 1 to 1027       1027/1063
(96 %)
29 diff
(97.3 %id)
AL048756 Kidney .k 818 to 1472 1 to 657       657/658
(99 %)
3 diff
(99.6 %id)
CN276532 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 826 to 1549 1 to 724       724/724
(100 %)
1 diff
(99.9 %id)
TI_151807431   .k 845 to 1485 99 to 739       641/739
(86 %)
7 diff
(99.1 %id)
CB266225 adipose .k 847 to 1501 1 to 654       654/654
(100 %)
2 diff
(99.7 %id)
BI255320 cervical carcinoma cell line, cervix .k 850 to 1511 1 to 662       662/664
(99 %)
3 diff
(99.6 %id)
TI_57188133   .k 850 to 1604 26 to 783       758/758
(100 %)
7 diff
(99.1 %id)
CD654827 Embryonic Stem cells .k 883 to 1666 4 to 779       776/815
(95 %)
17 diff
(98.0 %id)
CX867012 embryonic stem .k 896 to 1732 1 to 837       837/837
(100 %)
0 diff
(100 %id)
DQ185048   .k 897 to 1488 1 to 592       592/592
(100 %)
0 diff
(100 %id)
DA252304 caudate nucleus .k 907 to 1494 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BU838177 melanotic melanoma, cell line, skin .k 913 to 1662 1 to 752       752/881
(85 %)
13 diff
(98.6 %id)
CX872819 embryonic stem .k 921 to 1693 1 to 773       773/773
(100 %)
0 diff
(100 %id)
BU192562 eye, retinoblastoma .k 943 to 1855 1 to 914       914/914
(100 %)
7 diff
(99.3 %id)
BM762508 lymph node, stomach .k 943 to 1561 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CN276525 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 961 to 1721 1 to 764       764/764
(100 %)
3 diff
(99.7 %id)
ES315869 melanoma cell line .k 1012 to 1488 556 to 80     Submitted on the opposite strand 477/556
(85 %)
3 diff
(99.5 %id)
BM460397 eye, retinoblastoma .k 1016 to 1931 1 to 930       930/998
(93 %)
22 diff
(97.8 %id)
AA248607   .k 1037 to 1252 1 to 214       214/217
(98 %)
15 diff
(93.1 %id)
R58269   .k 1057 to 1201 30 to 174       148/174
(85 %)
10 diff
(94.3 %id)
TI_45212145   .k 1062 to 1776 90 to 805       716/805
(88 %)
6 diff
(99.3 %id)
TI_44345973   .k 1062 to 1686 96 to 720       625/720
(86 %)
6 diff
(99.2 %id)
BF908813.
matches multiple genes
uterus_tumor .k 1073 to 1297 235 to 13     Submitted on the opposite strand, also hits gene LOC150554 223/235
(94 %)
0 diff
(100 %id)
BM451811 eye, retinoblastoma .k 1108 to 1931 1 to 838       838/901
(93 %)
16 diff
(98.3 %id)
BG677976 skin, squamous cell carcinoma .k 1119 to 1913 1 to 799       799/891
(89 %)
15 diff
(98.4 %id)
AU137007 placenta .k 1129 to 1870 2 to 754   capped   753/754
(99 %)
16 diff
(97.9 %id)
BJ991399 hepatoblastoma .k 1137 to 1718 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM801868 eye, retinoblastoma .k 1141 to 1948 1 to 810       810/1163
(69 %)
10 diff
(99.2 %id)
BU186729 large cell carcinoma, lung .k 1159 to 1982 7 to 834       828/835
(99 %)
7 diff
(99.2 %id)
AW378407 head_neck .k 1160 to 1259 14 to 113       100/113
(88 %)
6 diff
(94.7 %id)
CD105427 brain, Pituitary .k 1170 to 2004 1 to 835       835/835
(100 %)
0 diff
(100 %id)
BM849311 myeloma .k 1187 to 1861 1 to 675       675/675
(100 %)
0 diff
(100 %id)
TI_57187152   .k 1188 to 1907 83 to 816       734/734
(100 %)
38 diff
(94.9 %id)
DA877125 Prostate .k 1234 to 1819 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
AU135283 placenta .k 1243 to 2048 2 to 818   capped   817/836
(97 %)
21 diff
(97.5 %id)
BM831368 stomach .k 1248 to 1864 1 to 617       617/617
(100 %)
0 diff
(100 %id)
AU252888 neuroblastoma .k 1253 to 1946 1 to 693       693/700
(99 %)
21 diff
(97.0 %id)
DB113076 thymus .k 1255 to 1838 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
CX872962 embryonic stem .k 1269 to 2066 1 to 798       798/798
(100 %)
0 diff
(100 %id)
EL954235 eyeball .k 1288 to 1715 17 to 445       429/445
(96 %)
6 diff
(98.7 %id)
BY995949   .k 1289 to 1998 22 to 731       710/731
(97 %)
6 diff
(99.2 %id)
CN276552 embryonic stem cells, cell lines H1, H7, andH9 .k 1291 to 1968 1 to 679       679/679
(100 %)
4 diff
(99.5 %id)
CB215935 normal endometrium, late proliferativephase, cycle day 13, uterus .k 1297 to 1915 1 to 619       619/619
(100 %)
0 diff
(100 %id)
AU137526 placenta .k 1305 to 2063 2 to 754   capped   753/852
(88 %)
14 diff
(98.4 %id)
AU117151 whole embryo, mainly head .k 1307 to 2041 2 to 737   capped   736/741
(99 %)
11 diff
(98.6 %id)
BX344107 Placenta Cot 25-normalized .k 1316 to 2267 1 to 948       948/948
(100 %)
18 diff
(98.2 %id)
BX359381 Placenta Cot 25-normalized .k 1316 to 2165 1 to 847       847/907
(93 %)
13 diff
(98.6 %id)
CN276563 embryonic stem cells, DMSO-treated H9 cellline .k 1317 to 2014 1 to 698       698/698
(100 %)
0 diff
(100 %id)
CN276620 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 1317 to 2038 1 to 722       722/722
(100 %)
0 diff
(100 %id)
BY800409 eye .k 1328 to 1939 1 to 612       612/612
(100 %)
0 diff
(100 %id)
TI_159724004   .k 1329 to 2210 948 to 81   AAA   868/998
(86 %)
25 diff
(97.5 %id)
BX446862 neuroblastoma .k 1333 to 2396 1 to 1070   fully sequenced,   1070/1070
(100 %)
4 diff
(99.7 %id)
CR607781 neuroblastoma .k 1333 to 3185 1 to 1853   tiling clone,   1853/1853
(100 %)
0 diff
(100 %id)
AL581540 B cells (Ramos cell line), B cells from Burkitt lymphoma .k 1337 to 2196 862 to 1   fully sequenced,   862/862
(100 %)
5 diff
(99.5 %id)
AU135007 placenta .k 1345 to 2180 2 to 852   capped   851/914
(93 %)
25 diff
(97.3 %id)
TI_154111727   .k 1369 to 2210 901 to 62   AAA   840/981
(85 %)
28 diff
(97.2 %id)
BE875236 large cell carcinoma, undifferentiated, lung .k 1379 to 1965 1 to 587       587/587
(100 %)
0 diff
(100 %id)
EH358665.
matches multiple genes
  .k 1386 to 1466 1 to 78   tiling clone, also hits gene LOC158383, YWHAZP5 78/80
(97 %)
4 diff
(95.0 %id)
TI_149276632   .k 1398 to 2210 880 to 75   AAA   806/806
(100 %)
14 diff
(98.3 %id)
BM802548 embryonal carcinoma, cell line, testis .k 1417 to 2454 1 to 1049       1049/1145
(91 %)
53 diff
(95.4 %id)
TI_153949347   .k 1426 to 1918 80 to 573       494/502
(98 %)
3 diff
(99.5 %id)
AU119998 whole embryo, mainly head .k 1438 to 2274 2 to 839   capped   838/839
(99 %)
7 diff
(99.2 %id)
AW629676 2 pooled high-grade transitional celltumors, genitourinary tract .k 1446 to 2041 1 to 597       597/601
(99 %)
6 diff
(99.1 %id)
CN276548 embryonic stem cells, DMSO-treated H9 cellline .k 1450 to 2038 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BY995371   .k 1451 to 2138 10 to 702       693/702
(98 %)
8 diff
(98.9 %id)
AU119924 whole embryo, mainly head .k 1455 to 2257 2 to 808   capped   807/807
(100 %)
3 diff
(99.7 %id)
TI_154039478   .k 1456 to 2210 845 to 100   AAA   746/906
(82 %)
15 diff
(98.4 %id)
AU135976 placenta .k 1485 to 2053 2 to 567   capped   566/667
(84 %)
12 diff
(98.3 %id)
TI_149307922   .k 1485 to 2210 831 to 107   AAA   725/924
(78 %)
9 diff
(99.1 %id)
TI_154105496   .k 1502 to 2221 833 to 117   AAA   717/900
(79 %)
18 diff
(98.0 %id)
BU686827 lung, Primary Lung Epithelial Cells .k 1505 to 2210 722 to 19   AAA   704/704
(100 %)
2 diff
(99.8 %id)
BU677311 lung, Primary Lung Epithelial Cells .k 1518 to 2210 711 to 19   AAA   693/693
(100 %)
2 diff
(99.8 %id)
CB054639 brain, glioblastoma (pooled) .k 1550 to 2210 693 to 26   AAA   668/668
(100 %)
4 diff
(99.5 %id)
AU141088   .k 1557 to 2368 2 to 813   capped   812/814
(99 %)
7 diff
(99.2 %id)
TI_154135727   .k 1568 to 2210 742 to 86   AAA   657/921
(71 %)
7 diff
(99.3 %id)
BQ311374 breast_normal .k 1570 to 1704 1 to 136       136/136
(100 %)
9 diff
(93.4 %id)
BU629938 cell lines, Chondrosarcoma .k 1585 to 2210 644 to 19   AAA   626/626
(100 %)
0 diff
(100 %id)
TI_57187532   .k 1599 to 2339 49 to 795       747/748
(99 %)
12 diff
(98.4 %id)
TI_154192060   .k 1606 to 2210 42 to 651   AAA   610/610
(100 %)
3 diff
(99.6 %id)
AU120783 whole embryo, mainly body .k 1619 to 2452 2 to 840   capped   839/841
(99 %)
7 diff
(99.2 %id)
BQ420672 embryonal carcinoma, cell line, testis .k 1629 to 2370 1 to 749       749/883
(84 %)
8 diff
(99.1 %id)
BF212078 bone marrow, from chronic myelogenous leukemia .k 1668 to 2010 1 to 346       346/884
(39 %)
15 diff
(98.4 %id)
CU446136 epidermis .k 1681 to 2418 25 to 770       746/770
(96 %)
8 diff
(99.0 %id)
TI_154135661   .k 1684 to 2202 632 to 108   AAA   525/782
(67 %)
0 diff
(100 %id)
TI_57228234   .k 1697 to 2423 49 to 788       740/744
(99 %)
29 diff
(96.2 %id)
CD239731 Pituitary .k 1709 to 2449 1 to 740       740/740
(100 %)
4 diff
(99.5 %id)
AU119338 whole embryo, mainly head .k 1727 to 2486 2 to 757   capped   756/758
(99 %)
8 diff
(99.0 %id)
BC070389 Bone marrow, chronic myelogenous leukemia .k 1781 to 3183 1 to 1403   available from MGC, AAA   1403/1403
(100 %)
3 diff
(99.8 %id)
BU190054 eye, retinoblastoma .k 1784 to 2696 1 to 921       921/921
(100 %)
13 diff
(98.6 %id)
CX868067 embryonic stem .k 1800 to 2538 1 to 739       739/739
(100 %)
0 diff
(100 %id)
TI_45215690   .k 1800 to 2554 88 to 850       763/851
(89 %)
11 diff
(98.8 %id)
AU119758 whole embryo, mainly head .k 1816 to 2614 2 to 807   capped   806/806
(100 %)
5 diff
(99.4 %id)
BQ229294 embryonal carcinoma, cell line, testis .k 1829 to 2616 1 to 792       792/885
(89 %)
9 diff
(99.0 %id)
TI_57228735   .k 1851 to 2570 53 to 783       731/891
(82 %)
11 diff
(98.8 %id)
AU143581   .k 1863 to 2685 2 to 819   capped   818/822
(99 %)
14 diff
(98.3 %id)
AA084684   .k 1876 to 2193 349 to 27   AAA   323/329
(98 %)
5 diff
(98.5 %id)
R51634 whole brain .k 1898 to 2210 327 to 13   AAA   315/315
(100 %)
7 diff
(97.8 %id)
CD244940 White Matter .k 1904 to 2719 1 to 819       819/819
(100 %)
3 diff
(99.7 %id)
BM689413 eye, Retina Foveal and Macular .k 1907 to 2298 9 to 400       392/400
(98 %)
0 diff
(100 %id)
DN602120 human embryonic stem cells .k 1924 to 2529 1 to 606       606/606
(100 %)
0 diff
(100 %id)
TI_154172636   .k 1924 to 2518 81 to 676       596/596
(100 %)
9 diff
(98.5 %id)
H23336 whole brain .k 1949 to 2309 1 to 365       365/365
(100 %)
7 diff
(98.1 %id)
H23337 whole brain .k 1949 to 2304 1 to 359       359/359
(100 %)
8 diff
(97.8 %id)
AI304857 carcinoid, lung .k 2031 to 2745 1 to 716     Submitted on the opposite strand 716/716
(100 %)
4 diff
(99.5 %id)
AA443870   .k 2057 to 2574 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
BU153511 large cell carcinoma, lung .k 2078 to 2948 1 to 879       879/881
(99 %)
13 diff
(98.6 %id)
CX782186 human embryonic stem cells .k 2086 to 2927 1 to 842       842/842
(100 %)
1 diff
(99.9 %id)
T40149 Liver .k 2091 to 2359 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BQ717671 sympathetic trunk .k 2093 to 2990 1 to 905       905/919
(98 %)
33 diff
(96.5 %id)
AW630847 2 pooled high-grade transitional celltumors, genitourinary tract .k 2095 to 2586 1 to 492       492/492
(100 %)
9 diff
(98.2 %id)
AL571893 placenta, Placenta Cot 25-normalized .k 2111 to 3137 1030 to 15       1016/1064
(95 %)
0 diff
(100 %id)
W67438 heart .k 2127 to 2586 1 to 462       462/462
(100 %)
2 diff
(99.6 %id)
R10530 liver and spleen .k 2135 to 2454 1 to 322       322/324
(99 %)
8 diff
(97.6 %id)
AV651299 corresponding non cancerous liver tissue .k 2138 to 2757 1 to 620     Submitted on the opposite strand 620/620
(100 %)
0 diff
(100 %id)
BU181295 large cell carcinoma, lung .k 2141 to 2981 1 to 847       847/896
(94 %)
9 diff
(99.0 %id)
CR608094 T cells (Jurkat cell line) .k 2154 to 3163 1 to 1010       1010/1010
(100 %)
0 diff
(100 %id)
AL557513 T cells (Jurkat cell line), T cells from T cell leukemia .k 2154 to 2662 1 to 509   fully sequenced,   509/509
(100 %)
0 diff
(100 %id)
CK821267 Pancreas, Purified pancreatic islet .k 2169 to 2762 1 to 594     Submitted on the opposite strand 594/594
(100 %)
0 diff
(100 %id)
TI_57228406   .k 2177 to 2599 384 to 824       707/773
(91 %)
48 diff
(93.8 %id)
CB151895 cervix, Uterine .k 2180 to 2794 1 to 615       615/615
(100 %)
0 diff
(100 %id)
CN276579 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 2230 to 2868 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BG289939 bladder, transitional cell papilloma, cell line .k 2231 to 2978 1 to 752       752/1102
(68 %)
15 diff
(98.7 %id)
H52620 liver and spleen .k 2233 to 2664 1 to 441       441/444
(99 %)
17 diff
(96.2 %id)
EH338135   .k 2240 to 2328 1 to 89       89/89
(100 %)
0 diff
(100 %id)
GD139225   .k 2240 to 2370 1 to 131       131/139
(94 %)
2 diff
(98.6 %id)
BM474475 leiomyosarcoma, uterus .k 2242 to 3126 1 to 893   AAA   893/973
(91 %)
12 diff
(98.8 %id)
TI_154113920   .k 2248 to 3183 1017 to 93   AAA   925/973
(95 %)
24 diff
(97.6 %id)
TI_59393303   .k 2258 to 2744 424 to 931       508/852
(59 %)
6 diff
(99.3 %id)
BQ959929 leiomyosarcoma, uterus .k 2265 to 3184 1 to 926       926/927
(99 %)
9 diff
(99.1 %id)
AL514197 neuroblastoma, placenta .k 2271 to 3295 1011 to 1       1011/1020
(99 %)
16 diff
(98.5 %id)
EH309030   .k 2272 to 2354 1 to 81       81/81
(100 %)
4 diff
(95.1 %id)
EH355541   .k 2287 to 2354 1 to 67       67/67
(100 %)
3 diff
(95.6 %id)
BM468643 leiomyosarcoma, uterus .k 2296 to 3298 1 to 1015       1015/1037
(97 %)
19 diff
(98.2 %id)
BY994762   .k 2305 to 3016 10 to 721       712/721
(98 %)
6 diff
(99.2 %id)
AA186511   .k 2310 to 2696 1 to 395       395/395
(100 %)
10 diff
(97.5 %id)
TI_149304284   .k 2314 to 3203 984 to 104   AAA   881/939
(93 %)
69 diff
(92.7 %id)
TI_154050250   .k 2315 to 3183 953 to 101   AAA   853/962
(88 %)
22 diff
(97.8 %id)
BG677193 skin, squamous cell carcinoma .k 2329 to 3171 1 to 840       840/841
(99 %)
13 diff
(98.5 %id)
BG119970 adenocarcinoma, cell line, Liver .k 2339 to 3083 1 to 740       740/806
(91 %)
9 diff
(98.9 %id)
BX435418 brain, fetal brain .k 2359 to 3166 807 to 1       807/843
(95 %)
34 diff
(96.0 %id)
H93857.
matches multiple genes
liver and spleen .k 2363 to 2793 1 to 441     also hits gene WAC 441/445
(99 %)
12 diff
(97.4 %id)
BX433804 neuroblastoma .k 2366 to 3185 823 to 1   fully sequenced,   823/823
(100 %)
15 diff
(98.2 %id)
TI_149286970   .k 2367 to 3183 879 to 73   AAA   807/1065
(75 %)
17 diff
(98.5 %id)
BX351912 Placenta Cot 25-normalized .k 2378 to 3176 806 to 5       802/875
(91 %)
0 diff
(100 %id)
H73474 liver and spleen .k 2387 to 2804 1 to 430       430/434
(99 %)
14 diff
(96.8 %id)
BQ947377 sciatic nerve .k 2392 to 3298 1 to 916       916/918
(99 %)
25 diff
(97.3 %id)
T61783 Liver .k 2399 to 2495 1 to 97       97/97
(100 %)
0 diff
(100 %id)
TI_154144169   .k 2403 to 3126 83 to 806       724/724
(100 %)
7 diff
(99.1 %id)
CV569476 cornea, eye .k 2430 to 3035 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM451129 eye, retinoblastoma .k 2431 to 3324 1 to 899       899/914
(98 %)
21 diff
(97.8 %id)
DB542180 hippocampus .k 2443 to 2919 1 to 477     Submitted on the opposite strand 477/478
(99 %)
1 diff
(99.8 %id)
BM972369 lung .k 2449 to 3183 752 to 19   AAA   734/734
(100 %)
1 diff
(99.9 %id)
ES316130 pool of melanoma cell lines .k 2451 to 2751 305 to 1     Submitted on the opposite strand 305/305
(100 %)
9 diff
(97.1 %id)
TI_149305673   .k 2459 to 3334 943 to 88   AAA   856/951
(90 %)
26 diff
(97.3 %id)
CA448875 Chondrosarcoma, Left Pelvis .k 2464 to 3183 737 to 19   AAA   719/719
(100 %)
1 diff
(99.9 %id)
BU856816 adenocarcinoma, cell line, breast .k 2467 to 3187 759 to 38   AAA Submitted on the opposite strand 722/949
(76 %)
7 diff
(99.3 %id)
AA453529   .k 2469 to 2985 1 to 518   fully sequenced,   518/518
(100 %)
17 diff
(96.8 %id)
CA413875 Chondrosarcoma Grade II, Left Pelvis .k 2474 to 3183 728 to 19   AAA   710/710
(100 %)
1 diff
(99.9 %id)
BM802363 eye, retinoblastoma .k 2489 to 3183 717 to 17   AAA Submitted on the opposite strand 701/889
(78 %)
11 diff
(98.8 %id)
EL953361 eyeball .k 2493 to 2978 11 to 496       486/496
(97 %)
6 diff
(98.8 %id)
EL954296 eyeball .k 2493 to 3037 20 to 564       545/564
(96 %)
6 diff
(99.0 %id)
EB387573 eye, optic nerve .k 2498 to 3224 1 to 727       727/727
(100 %)
0 diff
(100 %id)
BF834413 head_neck .k 2501 to 2793 1 to 293       293/297
(98 %)
17 diff
(94.3 %id)
CA418430 Chondrosarcoma Grade II, Left Pelvis .k 2507 to 3183 696 to 19   AAA   678/682
(99 %)
4 diff
(99.5 %id)
T98310 liver and spleen .k 2515 to 2976 15 to 473       459/473
(97 %)
6 diff
(98.8 %id)
BU951627 Pancreas, Purified pancreatic islet .k 2515 to 2977 1 to 464       464/464
(100 %)
10 diff
(97.9 %id)
R02671 liver and spleen .k 2516 to 2855 1 to 351       351/399
(87 %)
15 diff
(96.3 %id)
TI_149278706   .k 2522 to 3203 782 to 101   AAA   682/682
(100 %)
48 diff
(93.0 %id)
TI_154108887   .k 2522 to 3183 794 to 138   AAA   657/666
(98 %)
38 diff
(94.3 %id)
TI_57192057   .k 2523 to 2981 51 to 515       465/465
(100 %)
11 diff
(97.7 %id)
AA455007 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 2528 to 2962 1 to 435   fully sequenced,   435/435
(100 %)
0 diff
(100 %id)
BE091444 breast .k 2529 to 2916 388 to 5     Submitted on the opposite strand 384/394
(97 %)
0 diff
(100 %id)
AA461281   .k 2533 to 2900 136 to 503   fully sequenced,   368/503
(73 %)
5 diff
(99.1 %id)
W48610 senescent fibroblast .k 2537 to 2839 16 to 321       306/323
(94 %)
10 diff
(97.0 %id)
BM015554 breast, mammary adenocarcinoma, cell line .k 2541 to 3336 14 to 806       793/807
(98 %)
11 diff
(98.7 %id)
TI_59393802   .k 2541 to 3336 87 to 879       793/807
(98 %)
11 diff
(98.7 %id)
BG117433 adenocarcinoma, cell line, Liver .k 2542 to 3304 1 to 752       752/790
(95 %)
28 diff
(96.5 %id)
N31389 melanocyte .k 2546 to 2971 1 to 429   fully sequenced,   429/429
(100 %)
2 diff
(99.6 %id)
EH327370   .k 2558 to 2621 1 to 64       64/64
(100 %)
0 diff
(100 %id)
CX867983 embryonic stem .k 2561 to 3183 648 to 26   AAA   623/623
(100 %)
1 diff
(99.9 %id)
BM679194 eye, fetal eye .k 2568 to 3334 774 to 17   AAA   758/761
(99 %)
8 diff
(99.0 %id)
AL047008 uterus .k 2574 to 3183 1 to 610       610/620
(98 %)
1 diff
(99.9 %id)
TI_154120161   .k 2578 to 3334 844 to 94   AAA   751/963
(77 %)
25 diff
(97.5 %id)
TI_157594689   .k 2585 to 3184 687 to 81   AAA   607/609
(99 %)
26 diff
(95.8 %id)
EL951588 eyeball .k 2599 to 3182 45 to 626       582/626
(92 %)
6 diff
(99.1 %id)
AI573186 adenocarcinoma, Pancreas .k 2605 to 3364 765 to 11   tiling clone, AAA   755/760
(99 %)
11 diff
(98.6 %id)
AL579532 T cells (Jurkat cell line), T cells from T cell leukemia .k 2632 to 3163 532 to 1   fully sequenced,   532/532
(100 %)
4 diff
(99.3 %id)
BQ428062 leiomyosarcoma, uterus .k 2635 to 3334 1 to 700       700/722
(96 %)
2 diff
(99.8 %id)
CD365898 Alveolar Macrophage, lung .k 2637 to 3334 714 to 17   AAA   698/698
(100 %)
0 diff
(100 %id)
TI_59393115   .k 2638 to 2776 837 to 975       738/931
(79 %)
48 diff
(94.9 %id)
CK821268 Pancreas, Purified pancreatic islet .k 2646 to 3183 561 to 24   AAA Submitted on the opposite strand 538/538
(100 %)
0 diff
(100 %id)
AA779044   .k 2652 to 3184 542 to 9       534/542
(98 %)
0 diff
(100 %id)
W28878 eye, retina .k 2654 to 3323 694 to 18       677/893
(75 %)
0 diff
(100 %id)
BU685990 lung, Primary Lung Epithelial Cells .k 2656 to 3334 694 to 17   AAA   678/678
(100 %)
2 diff
(99.8 %id)
TI_154161071   .k 2662 to 3297 740 to 111   AAA Submitted on the opposite strand 630/663
(95 %)
10 diff
(98.5 %id)
TI_154133034   .k 2679 to 3233 664 to 109   AAA   556/919
(60 %)
19 diff
(98.0 %id)
TI_57228654   .k 2687 to 3224 214 to 763       550/763
(72 %)
6 diff
(99.3 %id)
BM697898 eye, fetal eyes .k 2688 to 3015 1 to 328   fully sequenced,   328/328
(100 %)
0 diff
(100 %id)
AA251298 germinal center B cell .k 2702 to 3184 484 to 2       483/484
(99 %)
0 diff
(100 %id)
FN098745 breast carcinoma .k 2708 to 2809 1 to 107       107/110
(97 %)
6 diff
(94.6 %id)
BE711086 head_neck .k 2712 to 2884 176 to 4       173/176
(98 %)
0 diff
(100 %id)
AA936040 metastatic prostate bone lesion .k 2715 to 3142 8 to 435       428/475
(90 %)
44 diff
(90.8 %id)
DB543613 hippocampus .k 2717 to 3183 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
DB543567 hippocampus .k 2720 to 3183 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
AA459540 ovarian tumor, ovary .k 2721 to 3010 1 to 286   fully sequenced,   286/286
(100 %)
0 diff
(100 %id)
DB527174 testis .k 2722 to 3183 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
BM993627 lung, Metastatic Chondrosarcoma .k 2730 to 3334 621 to 17   AAA   605/605
(100 %)
0 diff
(100 %id)
BE843252 testis_normal .k 2733 to 3023 312 to 18       295/312
(94 %)
0 diff
(100 %id)
AW575522 lymph .k 2739 to 3233 512 to 18   AAA   495/495
(100 %)
6 diff
(98.8 %id)
AW673788 cervix .k 2743 to 3335 593 to 1       593/593
(100 %)
11 diff
(98.2 %id)
AU145705 whole embryo, mainly head .k 2745 to 3334 590 to 1       590/600
(98 %)
9 diff
(98.5 %id)
DB521123 testis .k 2752 to 3183 1 to 432     Submitted on the opposite strand 432/432
(100 %)
0 diff
(100 %id)
DB559450 hypothalamus .k 2752 to 3181 1 to 430     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
DB560520 hypothalamus .k 2753 to 3183 1 to 431     Submitted on the opposite strand 431/431
(100 %)
7 diff
(98.4 %id)
TI_149276297   .k 2753 to 3183 525 to 94   AAA   432/932
(46 %)
1 diff
(99.9 %id)
BM995131 Chondrosarcoma, Left Pubic Bone .k 2755 to 3334 596 to 17   AAA   580/580
(100 %)
0 diff
(100 %id)
AU144058 whole embryo, mainly head .k 2758 to 3334 569 to 1       569/569
(100 %)
14 diff
(97.6 %id)
AU151082   .k 2758 to 3334 577 to 1       577/577
(100 %)
15 diff
(97.5 %id)
DB556599 hypothalamus .k 2763 to 3183 1 to 423     Submitted on the opposite strand 423/423
(100 %)
2 diff
(99.6 %id)
AU252889 neuroblastoma .k 2764 to 3335 589 to 20       570/700
(81 %)
0 diff
(100 %id)
EH320370.
matches multiple genes
  .k 2767 to 2830 1 to 64     also hits gene flarslaw, glodaw 64/64
(100 %)
2 diff
(96.9 %id)
EH354102.
matches multiple genes
  .k 2767 to 2830 1 to 64   tiling clone, also hits gene flarslaw 64/64
(100 %)
0 diff
(100 %id)
BY999700   .k 2770 to 3333 1 to 573     Submitted on the opposite strand 573/575
(99 %)
17 diff
(97.1 %id)
AU146020 whole embryo, mainly head .k 2774 to 3334 560 to 1       560/564
(99 %)
12 diff
(97.9 %id)
AU160773   .k 2774 to 3334 561 to 1       561/565
(99 %)
19 diff
(96.7 %id)
AW614874 2 pooled high-grade transitional celltumors, genitourinary tract .k 2775 to 3333 568 to 9       560/573
(97 %)
0 diff
(100 %id)
BJ991400 hepatoblastoma .k 2777 to 3316 540 to 1       540/540
(100 %)
0 diff
(100 %id)
CB146731 Liver .k 2779 to 3335 562 to 6     Submitted on the opposite strand 557/562
(99 %)
0 diff
(100 %id)
W43019 Pancreas, pancreatic islet .k 2782 to 3183 435 to 29   AAA   407/416
(97 %)
14 diff
(96.7 %id)
AU146142 whole embryo, mainly head .k 2789 to 3334 547 to 1       547/547
(100 %)
4 diff
(99.3 %id)
DB359597 whole embryo, mainly body .k 2795 to 3334 545 to 1       545/547
(99 %)
21 diff
(96.2 %id)
AU160650   .k 2795 to 3334 539 to 1       539/546
(98 %)
10 diff
(98.2 %id)
DB376797 placenta .k 2797 to 3334 535 to 1       535/545
(98 %)
13 diff
(97.7 %id)
AA863052 2 pooled tumors (clear cell type), Kidney .k 2799 to 3334 546 to 11   AAA   536/536
(100 %)
0 diff
(100 %id)
AA133376 lung, lung carcinoma .k 2803 to 3335 529 to 6     Submitted on the opposite strand 524/529
(99 %)
0 diff
(100 %id)
BE856257 brain, glioblastoma (pooled) .k 2803 to 3332 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AI817154 lymph node, lymphoma, follicular mixed small and largecell .k 2807 to 3183 410 to 33   AAA   378/378
(100 %)
22 diff
(94.2 %id)
AW504763 lymph .k 2810 to 3297 529 to 42   AAA Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AW627587 2 pooled high-grade transitional celltumors, genitourinary tract .k 2818 to 3334 517 to 1       517/517
(100 %)
14 diff
(97.3 %id)
DB375949 placenta .k 2821 to 3281 462 to 1       462/462
(100 %)
8 diff
(98.3 %id)
AI752888 bone marrow stroma .k 2838 to 3281 463 to 20   AAA   444/444
(100 %)
0 diff
(100 %id)
BG990865 head_neck .k 2839 to 2924 15 to 100       86/100
(86 %)
8 diff
(92.0 %id)
AA476721   .k 2842 to 3334 501 to 11   AAA   491/500
(98 %)
15 diff
(97.0 %id)
TI_154160718   .k 2847 to 3332 606 to 121   AAA Submitted on the opposite strand 486/545
(89 %)
0 diff
(100 %id)
DB577420 hypothalamus .k 2852 to 3187 1 to 337     Submitted on the opposite strand 337/337
(100 %)
6 diff
(98.3 %id)
DB545730 hippocampus .k 2855 to 3334 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
AI750195 Bone, Hip .k 2857 to 3225 402 to 34   AAA   369/369
(100 %)
0 diff
(100 %id)
DB550287 hippocampus .k 2867 to 3332 1 to 466     Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
DB540872 hippocampus .k 2868 to 3334 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AW950470   .k 2869 to 3296 1 to 434       434/484
(89 %)
21 diff
(95.7 %id)
AU146194 whole embryo, mainly head .k 2869 to 3334 466 to 1       466/468
(99 %)
0 diff
(100 %id)
AA460971   .k 2870 to 3337 468 to 1   fully sequenced,   468/468
(100 %)
2 diff
(99.6 %id)
BU726579 eye, Retina Foveal and Macular .k 2871 to 3334 480 to 17   AAA   464/464
(100 %)
1 diff
(99.8 %id)
BF155509 head_neck .k 2872 to 3281 439 to 31       409/439
(93 %)
0 diff
(100 %id)
C05697   .k 2878 to 3335 472 to 7       466/490
(95 %)
0 diff
(100 %id)
CX866640 embryonic stem .k 2887 to 3183 332 to 36   AAA   297/297
(100 %)
12 diff
(96.0 %id)
DB537986 hippocampus .k 2899 to 3332 1 to 434     Submitted on the opposite strand 434/434
(100 %)
1 diff
(99.8 %id)
W67439 heart .k 2905 to 3334 443 to 12   AAA   432/432
(100 %)
2 diff
(99.6 %id)
DB373344 placenta .k 2908 to 3334 428 to 1       428/430
(99 %)
4 diff
(99.1 %id)
AU155761 placenta .k 2916 to 3225 310 to 1       310/315
(98 %)
0 diff
(100 %id)
W48814 senescent fibroblast .k 2918 to 3334 436 to 14   AAA   423/425
(99 %)
11 diff
(97.5 %id)
CB133341 Liver .k 2918 to 3263 346 to 1     Submitted on the opposite strand 346/346
(100 %)
0 diff
(100 %id)
BF808596 colon_ins .k 2920 to 3312 394 to 1     Submitted on the opposite strand 394/394
(100 %)
6 diff
(98.5 %id)
DB374387 placenta .k 2925 to 3334 412 to 2       411/412
(99 %)
0 diff
(100 %id)
EC517167 Prostate .k 2931 to 3056 1 to 128       128/128
(100 %)
7 diff
(94.6 %id)
AA455008 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 2932 to 3334 417 to 15   fully sequenced, AAA   403/403
(100 %)
0 diff
(100 %id)
AA678777   .k 2938 to 3276 403 to 65       339/403
(84 %)
0 diff
(100 %id)
AW022156 cochlea, ear .k 2940 to 3334 1 to 395   AAA   395/395
(100 %)
5 diff
(98.8 %id)
N24094 melanocyte .k 2941 to 3339 402 to 4   fully sequenced,   399/402
(99 %)
4 diff
(99.1 %id)
AA453530   .k 2955 to 3335 381 to 1   fully sequenced,   381/381
(100 %)
0 diff
(100 %id)
BM672302 eye, human retina .k 2969 to 3334 384 to 19   AAA   366/366
(100 %)
4 diff
(99.0 %id)
R02553 liver and spleen .k 2976 to 3332 377 to 11   AAA   367/369
(99 %)
10 diff
(97.3 %id)
AA459309 ovarian tumor, ovary .k 2980 to 3334 355 to 1   fully sequenced,   355/355
(100 %)
0 diff
(100 %id)
DB513801 testis .k 2981 to 3334 1 to 356     Submitted on the opposite strand 356/356
(100 %)
4 diff
(98.9 %id)
AA182818   .k 2982 to 3326 345 to 1       345/463
(74 %)
6 diff
(98.8 %id)
BM667073 eye, fetal eyes .k 2985 to 3334 368 to 19   fully sequenced, AAA   350/350
(100 %)
0 diff
(100 %id)
H52621 liver and spleen .k 2991 to 3302 321 to 1       321/329
(97 %)
9 diff
(97.3 %id)
AA514844 breast .k 2999 to 3262 264 to 1       264/264
(100 %)
0 diff
(100 %id)
H73728 liver and spleen .k 3000 to 3330 339 to 1       339/371
(91 %)
16 diff
(95.7 %id)
BM783874 stomach .k 3009 to 3334 1 to 326   AAA   326/326
(100 %)
0 diff
(100 %id)
R10122 liver and spleen .k 3027 to 3330 307 to 1       307/307
(100 %)
4 diff
(98.7 %id)
BF675169 Prostate .k 3029 to 3327 1 to 298   AAA   298/298
(100 %)
1 diff
(99.7 %id)
BE073944 breast .k 3033 to 3330 300 to 1     Submitted on the opposite strand 300/309
(97 %)
10 diff
(96.8 %id)
BM694042 eye, Retina Foveal and Macular .k 3040 to 3253 1 to 214   fully sequenced,   214/214
(100 %)
0 diff
(100 %id)
AA334751   .k 3048 to 3334 287 to 1     Submitted on the opposite strand 287/287
(100 %)
0 diff
(100 %id)
AW504544 lymph .k 3048 to 3334 326 to 40   AAA Submitted on the opposite strand 287/287
(100 %)
3 diff
(99.0 %id)
BE243702 leukopheresis .k 3050 to 3332 283 to 1       283/283
(100 %)
4 diff
(98.6 %id)
AA580920 bulk germ cell seminoma .k 3090 to 3335 254 to 8       247/254
(97 %)
0 diff
(100 %id)
H23224 whole brain .k 3092 to 3333 264 to 19       246/275
(89 %)
0 diff
(100 %id)
AW370804.
matches multiple genes
breast .k 3125 to 3323 213 to 18   tiling clone, also hits gene flarslaw 196/216
(90 %)
0 diff
(100 %id)
R31586 placenta .k 3129 to 3330 203 to 1       203/203
(100 %)
2 diff
(99.1 %id)
AW370793 breast .k 3135 to 3333 9 to 203       195/216
(90 %)
6 diff
(97.3 %id)
AA648559 Ewing's sarcoma .k 3139 to 3334 1 to 196   AAA   196/196
(100 %)
1 diff
(99.5 %id)
T61758 Liver .k 3144 to 3334 210 to 20   AAA   191/191
(100 %)
2 diff
(99.0 %id)
ES274078 rectum .k 3150 to 3332 210 to 28   AAA Submitted on the opposite strand 183/183
(100 %)
1 diff
(99.5 %id)
BQ948867 sciatic nerve .k 3167 to 3334 1 to 168   AAA   168/168
(100 %)
0 diff
(100 %id)
BE833398 ovary .k 3178 to 3328 169 to 19       151/184
(82 %)
0 diff
(100 %id)
BM843015 lymph node, stomach .k 3216 to 3731 1 to 531   tiling clone,   531/531
(100 %)
10 diff
(98.2 %id)
BM665793 eye, Retina Foveal and Macular .k 3223 to 3334 129 to 17   fully sequenced, AAA   113/113
(100 %)
1 diff
(99.2 %id)
BG896517 cartilage .k 3701 to 4027 83 to 410   tiling clone,   328/343
(95 %)
4 diff
(98.9 %id)
CB151564 cervix, Uterine .k 3723 to 4260 1 to 538       538/538
(100 %)
6 diff
(98.9 %id)
BE748398 bone marrow, from acute myelogenous leukemia .k 3745 to 4330 1 to 585       585/587
(99 %)
8 diff
(98.7 %id)
AA553832 colon, tumor .k 3822 to 4209 388 to 1       388/388
(100 %)
5 diff
(98.8 %id)
F13264 brain, total brain .k 3842 to 4176 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
U79277 brain .k 3842 to 5386 1 to 1545   tiling clone, AAA   1545/1545
(100 %)
0 diff
(100 %id)
T77080 whole brain .k 3872 to 4281 1 to 409       409/409
(100 %)
10 diff
(97.6 %id)
BF921330 nervous_tumor .k 3891 to 4385 507 to 14     Submitted on the opposite strand 494/537
(91 %)
0 diff
(100 %id)
BQ344462 nervous_tumor .k 3891 to 4314 425 to 2       424/449
(94 %)
0 diff
(100 %id)
BF920866 nervous_tumor .k 3892 to 4385 505 to 13     Submitted on the opposite strand 493/505
(97 %)
0 diff
(100 %id)
BE928399 colon .k 3934 to 4252 9 to 323       315/323
(97 %)
6 diff
(98.2 %id)
BE928403 colon .k 3936 to 4252 1 to 306       306/306
(100 %)
15 diff
(95.1 %id)
BE928398 colon .k 3979 to 4252 1 to 268       268/268
(100 %)
11 diff
(95.9 %id)
BE928374 colon .k 3983 to 4252 1 to 270       270/270
(100 %)
20 diff
(92.6 %id)
BE748919 bone marrow, from acute myelogenous leukemia .k 4174 to 4975 805 to 2       804/975
(82 %)
0 diff
(100 %id)
CA424510 cell lines, Chondrosarcoma .k 4297 to 5043 760 to 19   AAA   742/742
(100 %)
3 diff
(99.6 %id)
AA147610 uterus .k 4498 to 5028 1 to 528   fully sequenced,   528/528
(100 %)
7 diff
(98.7 %id)
BF594442 colon, colon tumor, RER+ .k 4505 to 5043 534 to 1       534/534
(100 %)
2 diff
(99.7 %id)
AI373874 uterus .k 4576 to 5043 485 to 23   AAA   463/463
(100 %)
3 diff
(99.4 %id)
AI983617 colon, colonic mucosa from 3 patients with Crohn'sdisease .k 4577 to 5053 476 to 5       472/476
(99 %)
0 diff
(100 %id)
AA147618 uterus .k 4686 to 5043 353 to 1   fully sequenced,   353/353
(100 %)
2 diff
(99.5 %id)
AW183780 pooled .k 4732 to 5043 307 to 1       307/307
(100 %)
3 diff
(99.1 %id)
DA302997 hippocampus .k 4738 to 5308 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BX112173 whole brain .k 5052 to 5386 349 to 15     Submitted on the opposite strand 335/349
(95 %)
0 diff
(100 %id)
F11091 brain, total brain .k 5103 to 5386 284 to 1       284/284
(100 %)
0 diff
(100 %id)
BQ430265 epithelioid carcinoma, Pancreas .l 1 to 662 1 to 662 Q227K G228E D229T E230K A231L ... tiling clone,   841/852
(98 %)
14 diff
(98.4 %id)
AK315867   .m 1 to 1370 1 to 1370 exact tiling clone,   1370/1370
(100 %)
1 diff
(100.0 %id)
DC371616   .m 1 to 566 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
CR991300 T-Lymphocytes .n 1 to 883 12 to 894 exact tiling clone,   883/894
(98 %)
5 diff
(99.5 %id)
AK294647 brain .o 1 to 1399 1 to 1404 exact tiling clone,   1404/1404
(100 %)
2 diff
(99.9 %id)
DC319643 brain .o 1 to 496 1 to 496       496/496
(100 %)
0 diff
(100 %id)
AK296902 tongue, tumor tissue .p 1 to 1353 1 to 1353 D66G tiling clone,   1353/1357
(99 %)
2 diff
(99.9 %id)
DC347313 tongue, tumor tissue .p 1 to 563 1 to 563 D66G     563/563
(100 %)
1 diff
(99.9 %id)
DC315092 amygdala .q 1 to 590 1 to 590 exact tiling clone,   590/590
(100 %)
0 diff
(100 %id)
BG719052 testis .r-u 1 to 628 1 to 639 K25G P64T P72T H73P H74S ... tiling clone,   639/643
(99 %)
36 diff
(94.5 %id)
AW884780 ovary .r-u 105 to 327 225 to 5   tiling clone,   221/236
(93 %)
0 diff
(100 %id)
AI017745   .r-u 295 to 604 1 to 310   tiling clone, Submitted on the opposite strand 310/310
(100 %)
1 diff
(99.7 %id)
FN174445 breast carcinoma .r-u 387 to 459 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
CR745565   .s 1 to 265 265 to 1   tiling clone, Submitted on the opposite strand 265/273
(97 %)
0 diff
(100 %id)
BG718799 testis .s 73 to 717 1 to 647   tiling clone,   647/648
(99 %)
7 diff
(99.0 %id)
BI464712 testis .s 73 to 704 1 to 640       640/768
(83 %)
41 diff
(94.7 %id)
DB450691 testis .s 155 to 644 1 to 491       491/491
(100 %)
4 diff
(99.2 %id)
BG704445 brain, hippocampus .s 163 to 903 1 to 748       748/748
(100 %)
35 diff
(95.4 %id)
CN281957 embryonic stem cells, cell lines H1, H7, andH9 .s 199 to 482 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
BE780714 eye, retinoblastoma .s 233 to 1052 1 to 809       809/886
(91 %)
47 diff
(94.7 %id)
BM462823 melanotic melanoma, skin .s 296 to 768 9 to 483       475/1084
(43 %)
6 diff
(99.5 %id)
BG424357 Kidney, renal cell adenocarcinoma .s 310 to 1007 1 to 729       729/1132
(64 %)
67 diff
(94.1 %id)
CN289164 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .s 313 to 774 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BU539485 adenocarcinoma, cell line, breast .s 314 to 1075 1 to 765   tiling clone,   765/870
(87 %)
7 diff
(99.2 %id)
BG422321 Kidney, renal cell adenocarcinoma .s 324 to 1029 1 to 710       710/746
(95 %)
12 diff
(98.4 %id)
CN484823 eye .s 359 to 929 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
AA884536   .s 821 to 1184 1 to 362   tiling clone, Submitted on the opposite strand 362/362
(100 %)
2 diff
(99.5 %id)
BI059028 placenta_normal .t-u 1 to 473 481 to -3   tiling clone,   479/481
(99 %)
0 diff
(100 %id)
DA460339 tongue, tumor tissue .t-u 1 to 552 2 to 554   tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
AL712257 human skeletal muscle .t-u 427 to 981 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
BQ082366 Ascites, stomach .t-u 449 to 1043 1 to 595   tiling clone,   595/611
(97 %)
0 diff
(100 %id)
BI027014 marrow .t-u 950 to 1134 185 to 1   tiling clone,   185/185
(100 %)
2 diff
(99.0 %id)
AW993060 breast_normal .t-u 963 to 1119 160 to 3     Submitted on the opposite strand 158/160
(98 %)
0 diff
(100 %id)
BE061738 breast .t-u 963 to 1161 1 to 199       199/202
(98 %)
5 diff
(97.6 %id)
BI026907 marrow .t-u 976 to 1134 1 to 157       157/157
(100 %)
6 diff
(96.2 %id)
DB258013 uterus .t-u 1044 to 1596 2 to 553   tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DB351503 uterus .t-u 2851 to 3387 537 to 1 exact tiling clone,   537/537
(100 %)
0 diff
(100 %id)
DA944241 Spleen .u-u 1 to 568 2 to 570 L52X F53V L54F N55K L56P ... tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
EH358665.
matches multiple genes
  P5.a-u 1 to 81 1 to 78 Y7I T8Q tiling clone, also hits gene LOC158383, YWHAZP5 78/80
(97 %)
4 diff
(95.0 %id)
AK307506 brain Gene YWHAZ, variant not shown         Suspected internal deletion, this clone was ignored    
BF725367 eye, Iris Gene YWHAZ, variant not shown         This clone was ignored    
DC350659 brain Gene YWHAZ, variant not shown         Suspected internal deletion, this clone was ignored    
AF074984   Gene YWHAZ, variant not shown         This clone was ignored    
AA581681 Kidney, kidney tumor Gene YWHAZ, variant not shown         This clone was ignored    
AA808812 Kidney, kidney tumor Gene YWHAZ, variant not shown         This clone was ignored    
DC364904   Gene YWHAZ, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t-u, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI